alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › expanding

expanding

2 studies tagged expanding, dated 2019-12-18 to 2025-04-17. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. The Expanding Role of GLP-1 Receptor Agonists: Advancing Clinical Outcomes in Metabolic and Mental Health 2025-04-17
  2. Expanding therapeutic opportunities for neurodegenerative diseases: A perspective on the important role of phenotypic screening 2019-12-18

Studies

2 studies carry this tag.

Date range

2019 to 2025

Top journals

  • Bioorganic & medicinal chemistry 1
  • Current issues in molecular biology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. The Expanding Role of GLP-1 Receptor Agonists: Advancing Clinical Outcomes in Metabolic and Mental Health

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Current issues in molecular biology 2025-04-17 Drug development

    Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have emerged as a promising therapeutic option beyond their established role in managing type 2 diabetes mellitus (T2DM) and obesity.

  2. Expanding therapeutic opportunities for neurodegenerative diseases: A perspective on the important role of phenotypic screening

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Bioorganic & medicinal chemistry 2019-12-18 Drug development

    Over the last 20 years, there have been remarkably few FDA-approved first-in-class drugs for neurodegenerative diseases.

All topic tags with their study counts